Billionbrains Garage Ventures operates Groww, an Indian retail investing platform whose revenue still comes mainly from broking, with a growing MTF interest book and a small but strategically important wealth and asset-management franchise. The investment case is an operating-leverage story: roughly 90% of costs are fixed, so revenue growth above the guided cost-growth range should flow disproportionately to EBITDA. The important qualification after Q2 FY27 is that the cost base is not static. Management guides cost to grow at roughly ₹400-500 crores a year and can flex it down when markets are weak, but employee cost is structurally rising and cost to serve is increasing with AI and compute. The thesis therefore depends less on a single fixed-cost pool and more on revenue growth outrunning a mixed cost base.
The near-term earnings engine is MTF. Management reconfirmed in Q2 FY27 that the book is adding ₹600-700 crores per quarter and said MTF was slightly above 5% of cash turnover, up from the prior 3-4% range. MTF earns a fixed 14.95% and also lifts cash-segment revenue per order because the funded portion is counted in cash revenue. As the book grows, management expects the MTF share of cash turnover to rise, though not proportionally, because churn and volatility affect the ratio. That is a real but market-sensitive earnings lever: the book is marked to market and can shrink at quarter-end when markets fall. Q2 FY27 had some MTF cost but no one-off, unlike the prior risk costs from commodity and MTF volatility. The distinction matters. The MTF mechanism is intact; the risk is that a sharp market fall interrupts the compounding and creates credit costs at the same time.
Cash yields are the second near-term lever. Management said in July 2026 that cash yields had improved roughly 5% year-on-year and expected 1-2% quarterly gains as MTF penetration rises. Q2 FY27 supported the direction, with MTF above 5% of cash turnover, but did not repeat the quarterly yield target. The inference is that cash yield continues to grind up as MTF penetration rises and customers age into larger ticket sizes. That inference is supported by management's comment that older customers do larger turnover and that MTF growth lifts cash turnover. It is not a guarantee, because cash revenue is a mix of order size and number of orders, priced at 10 basis points or ₹20, whichever is lower. Derivatives and commodities are charged per order, so their revenue is linked to orders rather than ADTV. This means ADTV market-share data can mislead on revenue.
The medium-term diversification is wealth and asset management. Q2 FY27 published total wealth AUM for the first time but declined to split MF Prime and W. Management said MF Prime is very small but the fastest-growing part, and wealth users rose about 50% QoQ, mostly through Prime. Fisdom integration is done, with some products going mainstream across apps, but some products are still being figured out. The combined Fisdom and AMC contribution was under 2% of total income as of the last disclosure, and Q2 did not update revenue. The State Street investment in the AMC has SEBI and CCI approval, bringing global passive and quant practices and capital to scale a sub-scale AMC. These are real optionalities, but none is yet a material revenue line. The wealth thesis is not that Fisdom suddenly becomes large; it is that Groww already has affluent customers with 37% of total customer assets and can cross-sell wealth products at near-zero acquisition cost. That mechanism remains intact, but disclosure is still thin.
US stocks via GIFT City is a third optionality. The product is licensed and in testing, with good customer feedback, but management has no full-launch timeline. It should be treated as an option, not a forecast. The same applies to 915: Q2 FY27 said it is not a material contributor to volume or revenue and has not yet proven product-market fit. The company is not relying on 915 to drive the near-term earnings path.
Capital allocation is conservative. Q2 FY27 disclosed no new company-funded capex. The State Street investment is incoming capital to the AMC, not Groww capex. The Fisdom acquisition is completed and integrated. The balance sheet remains strong, and management has said the AMC has enough capital after the State Street transaction to pursue inorganic opportunities if the right asset appears. The absence of new capex is not a problem for the thesis; the business is asset-light, and the main investment is people and technology, which flows through cost to serve and employee cost rather than a capex line.
Management delivery is mixed but broadly credible. LAS was launched and scaled to 34% of disbursements. Commodities reached a claimed 28% retail notional ADTO share. The MTF run-rate was reconfirmed. Against that, wealth/Fisdom revenue disclosure has been deferred repeatedly, 915 data never arrived quantitatively, and US stocks still has no launch date. These are not failures yet, because no hard deadline was attached to most of them, but they mean the market should not capitalise wealth or US stocks as if they were already delivering.
The falsifiers are specific. First, if CAS normalises derivatives volumes without lifting them and volatility stays low, the derivatives revenue base may not recover as expected. Management explicitly said it expects normalisation, not an increase. Second, if MTF accretion slows below ₹600 crores a quarter or the book shrinks with a market fall, the near-term earnings lever weakens. Third, if cost to serve and employee costs keep rising faster than revenue, the operating-leverage thesis fails even if revenue grows. Fourth, if wealth and Fisdom revenue stay below 2% and the Prime/W disclosure remains opaque, the diversification thesis remains an aspiration. Fifth, if discount brokers cutting brokerage or AI-led tools pressure Groww's pricing or acquisition cost, the organic funnel advantage narrows. The thesis is not broken by any one of these, but the combination would compress the earnings path that the operating-leverage case depends on.
Inference versus guidance: management guides MTF additions, cost to grow, employee cost direction, CAS normalisation, and UPI MDR non-materiality. The analyst inference is that MTF and cash yields can compound enough to offset slower derivatives growth and a rising cost base. That inference requires market conditions that support MTF and derivatives activity, and it requires wealth/Fisdom to become a real contributor before the derivatives base matures. The evidence supports the direction but not the speed.
companyname: Billionbrains Garage Ventures Limited ticker: GROWW sector: Financial Services / Online Broking & Wealth Management Groww is an Indian retail investing platform founded in 2016 by Lalit Keshre, Harsh Jain, Ishan Bansal, and Neeraj Singh, and listed on NSE/BSE in November 2025. It started as a mutual fund distribution platform and expanded into stocks, derivatives, commodities, margin trading, bonds, consumer credit, wealth management, and asset management. As of March 31, 2026, it ...
Read the full report →none
Management expects MTF book additions of ₹600-700 crores per quarter to continue and expects the MTF share of cash turnover to rise as the book grows. Cost to grow is guided at roughly ₹400-500 crores a year, with quarterly spend flexible around a ~₹125 crore average; a good year can exceed ₹500 crores and a bad year can be closer to ₹400 crores. Employee cost is expected to stay around the latest quarter structurally and not decline. CAS is expected to normalise derivatives volumes rather than lift them, and proposed UPI MDR is not expected to be material pending final rates and caps.
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Billionbrains Garage Ventures Ltd and 4,900+ companies.
5-day free pass. No card required.